Moving beyond food noise to drug noise, GLP-1s are quieting the roar of addiction. Cai M, Choi T, Xie Y, Al-Aly Z
A coordinated plan beats a stack of disconnected molecules
Novo has increasingly leaned into oral obesity drugs as a major competitive advantage after the launch of its Wegovy pill generated more than 1.3 million prescriptions during the first quarter
Both SGLT-2 inhibitors and GLP-1 receptor agonists can be effective first-line glucose-lowering drugs for cardiovascular patients, regardless of whether metformin was used at baseline
Your energy's climbing, your mood's stabilizing, and you're finally feeling like yourself again
Reduced Depression and Anxiety The research on how GLP-1 drugs may benefit depression is mixed